Silo Pharma gets notice of allowance for Canadian PTSD patent application
Silo Pharma (SILO) received a notice of allowance for a Canadian patent application covering a novel PTSD treatment, per the Newsdesk alert.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.